We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




CT-Based Radiomics Deep Learning Predicts Lymph Node Metastasis in Tumors

By MedImaging International staff writers
Posted on 24 Jan 2024
Image: The AI model has demonstrated an 89% success rate in predicting lymph node metastasis (Photo courtesy of 123RF)
Image: The AI model has demonstrated an 89% success rate in predicting lymph node metastasis (Photo courtesy of 123RF)

Nonfunctional pancreatic neuroendocrine tumors, although uncommon, are primarily managed through surgical intervention. The decision-making process for surgery and other treatments is heavily influenced by the presence or absence of lymph node metastasis. There is currently a lack of consensus in clinical guidelines, especially regarding the necessity of surgery for tumors less than 2 cm in size. The preoperative diagnosis of lymph node metastasis through existing methods is not sufficiently reliable. To address this, researchers have now introduced an imaging model that combines radiomics (the extraction of data from radiological images) and deep learning to predict preoperative lymph node metastasis in these tumors. This innovative model marks a significant step forward in the non-invasive assessment of lymph node metastasis, facilitating more precise diagnosis and aiding in the determination of the most effective treatment strategies.

The team at the University of Tsukuba (Tsukuba, Japan) developed this predictive model by integrating radiomics features obtained from CT and MRI scans with advanced artificial intelligence deep-learning techniques. Impressively, this model exhibited an 89% accuracy rate in predicting lymph node metastasis, which further increases to 91% when validated with data from an external hospital. Remarkably, its performance remains stable regardless of whether the tumor size is above or below 2 cm. This model thus serves as a vital tool for predicting lymph node metastasis, equipping surgeons with essential information to select the most suitable surgical interventions and treatment plans. The development holds the potential to significantly improve patient outcomes in this challenging medical field.

Related Links:
University of Tsukuba

Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mammography System (Analog)
MAM VENUS
Multi-Use Ultrasound Table
Clinton
Digital Radiographic System
OMNERA 300M

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.